Treatment of menorrhagia

American Family Physician

Volumn 75, Issue 12, 2007, Pages 1813-1819

  Apgar, Barbara S ^a,b   Kaufman, Amanda H ^a   George Nwogu, Uche ^a   Kittendorf, Anne ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADENOCARCINOMA; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CANCER DIAGNOSIS; DIAGNOSTIC TEST; ENDOMETRIUM ABLATION; ENDOMETRIUM BIOPSY; ENDOMETRIUM POLYP; FERTILITY; HUMAN; HYSTEROSCOPY; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; MORBIDITY; QUALITY OF LIFE; REVIEW; RISK FACTOR; UTERUS MYOMA; VAGINAL HYSTERECTOMY;

ADULT; BIOPSY; CATHETER ABLATION; ENDOMETRIUM; FEMALE; HUMANS; HYSTEROSCOPY; LASER SURGERY; LEIOMYOMA; MENORRHAGIA; MENSTRUATION; PROGESTINS; UTERINE NEOPLASMS;

EID: 34250724933     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. ACOG Committee on Practice Bulletins - Gynecology. ACOG practice bulletin: management of anovulatory bleeding. Int J Gynaecol Obstet 2001;72:263-71.
2. Iyer V, Farquhar C, Jepson R. Oral contraceptive pills for heavy menstrual bleeding. Cochrane Database Syst Rev 2000;(2):CD000154.
3. Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss - a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966;45:320-51.
4. Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD. Menorrhagia II: is the 80-mL blood loss criterion useful in management of complaint of menorrhagia? Am J Obstet Gynecol 2004;190:1224-9.
5. Wyatt KM, Dimmock PW, Walker TJ, O'Brien PM. Determination of total menstrual blood loss. Fertil Steril 2001;76:125-31.
6. Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol 2004;190:1216-23.
7. Lethaby A, Hickey M, Garry R. Endometrial destruction techniques for heavy menstrual bleeding. Cochrane Database Syst Rev 2005;(4):CD001501.
8. Janssen CA, Scholten PC, Heintz AP. Menorrhagia - a search for epidemiological risk markers. Maturitas 1997;28:19-25.
9. Wegienka G, Baird DD, Hertz-Picciotto I, Harlow SD, Steege JF, Hall MC, et al. Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol 2003;101:431-7.
10. DeWaay DJ, Syrop CH, Nygaard IE, Davis WA, Van Voorhis BJ. Natural history of uterine polyps and leiomyomata. Obstet Gynecol 2002;100:3-7.
11. Philipp CS, Faiz A, Dowling N, Dilley A, Michaels LA, Ayers C, et al. Age and prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol 2005;105:61-6.
12. Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. Von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004;111:734-40.
13. James A, Matcher DB, Myers ER. Testing for von Willebrand disease in women with menorrhagia: a systematic review. Obstet Gynecol 2004;104:381-8.
14. ACOG Committee on Gynecologic Practice. Committee Opinion: No. 263, December 2001. Von Willebrand's disease in gynecologic practice. Obstet Gynecol 2001;98:1185-6.
15. Royal College of Obstetricians and Gynaecologists. National evidence-based clinical guidelines: the management of menorrhagia in secondary care. Accessed January 23, 2007, at: http://www.rcog.org.uk/index/asp?PageID= 692.
16. American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, No. 65, August 2005. Management of endometrial cancer. Obstet Gynecol 2005;106:413-25.
17. Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 2000;89:1765-72.
18. Clark TJ, Mann CH, Shah N, Khan KS, Song F, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. BJOG 2002;109:313-21.
19. Mihm LM, Quick VA, Brumfield JA, Connors AF Jr, Finnerty JJ. The accuracy of endometrial biopsy and saline sonohysterography in the determination of the cause of abnormal uterine bleeding. Am J Obstet Gynecol 2002;186:858-60.
20. Dijkhuizen FP, Mol BW, Bongers MY, Brolmann HA, Heintz AP. Cost-effectiveness of transvaginal sonography and saline infused sonography in the evaluation of menorrhagia. Int J Gynecol Obstet 2003;83:45-52.
21. de Kroon CD, de Bock GH, Dieben SW, Jansen FW. Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG 2003;110:938-47.
22. Breitkopf D, Goldstein SR, Seeds JW, for the ACOG Committee on Gynecologic Practice. ACOG technology assessment in obstetrics and gynecology, No. 3, September 2003. Saline infusion sonohysterography. Obstet Gynecol 2003;102:659-62.
23. Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 2002;288:1610-21.
24. de Vries LD, Dijkhuizen FP, Mol BW, Brolman HA, Moret E, Heintz AP. Comparison of transvaginal sonography, saline infusion sonography, and hysteroscopy in premenopausal women with abnormal uterine bleeding. J Clin Ultrasound 2000;28:217-23.
25. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivela A, et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 2001;357:273-7.
26. Lethaby A, Irvine G, Cameron I. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 1998;(4):CD001016.
27. Miller L, Hughes JP. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstet Gynecol 2003;101:653-61.
28. Lethaby A, Augood C, Duckitt K. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 1998;(3):CD000400.
29. Beaumont H, Augood C, Duckitt K, Lethaby A. Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev 2002;(2):CD001017.
30. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Databse Syst Rev 2000;(4):CD000249.
31. Lethaby AE, Cooke I, Rees M. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding. Cochrane Database Syst Rev 2005;(4):CD002126.
32. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivela A, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004;291:1456-63.
33. Lahteenmaki P, Haukkamaa M, Puolakka J, Riikonen U, Sainio S, Suvisaari J, et al. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ 1998;316:1122-6.
34. Sowter MC, Lethaby A, Singla AA. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding. Cochrane Database Syst Rev 2002;(3):CD001124.
35. Abbott JA, Garry R. The surgical management of menorrhagia. Hum Reprod Update 2002;8:68-78.
36. Sowter MC. New surgical treatments for menorrhagia. Lancet 2003;361:1456-8.
37. Lethaby A, Shepperd S, Cooke I, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev 1999;(2):CD000329.
38. Bourdrez P, Bongers MY, Mol BW. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel- releasing intrauterine device, or hysterectomy. Fertil Steril 2004;82:160-6.
39. Kennedy AD, Sculpher MJ, Coulter A, Dwyer N, Rees M, Abrams KR, et al. Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs: a randomized controlled trial [Published correction appears in JAMA 2003;289:703]. JAMA 2002;288:2701-8.
40. Abbott JA, Hawe J, Garry R. Quality of life should be considered the primary outcome for measuring success of endometrial ablation. J Am Assoc Gynecol Laparosc 2003;10:491-5.
41. Cooper KG, Jack SA, Parkin DE, Grant AM. Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. BJOG 2001;108:1222-8.
42. Learman LA, Summitt RL Jr, Varner RE, Richter HE, Lin F, Ireland CC, et al. Hysterectomy versus expanded medical treatment for abnormal uterine bleeding: clinical outcomes in the medicine or surgery trial. Obstet Gynecol 2004;103(5 pt 1):824-33.
43. Kuppermann M, Varner RE, Summitt RL Jr, Learman LA, Ireland C, Vittinghoff E, et al., for the Ms Research Group. Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial. JAMA 2004;291:1447-55.
44. Abbott J. Immediate endometrial resection for menorrhagia was more effective in the long term than initial medical management [Commentary]. Evidence-based Obstet Gynecol 2002;4:126-7.